This new position paper highlights the role of Voluntary Trade Organizations (VTOs) in the French retail drug supply and their impact on pharma companies’ business.
The following insights are covered:
- French drug market structure and its supply chain (2023)
- Share of revenues by stakeholder for reimbursable drugs (2023)
- Bridge from ex-factory to public price for retail reimbursable generics
- Pre-wholesalers, wholesalers and VTOs roles and activities
- Segmentation of VTOs based on coverage and centralization level
- VTOs key purchasing criteria
- VTOs strategic moves and implications for generics companies